NorthWest Biotherapeutics Inc (NWBO)

[OncoJock]

Could some smart person please explain to me what, exactly, we are manufacturing now at Sawston and in London that costs more than $1 million per month? The clinical trial is long over, and we do not yet have commercial authorization to market a product. We have been told that combination trials are on hold pending additional resources, and that much of management's time and attention has been focused on preparing for MHRA inspections associated with the marketing authorization application.

Are these manufacturing expenses associated with producing doses of DCVax-L for the "specials" we keep hearing about? And if so, how come there are almost no sales revenues ($794K since Jan. 1 2024) to offset more than $8 million in manufacturing expenses? Are we selling doses to private pay clients at a 90% discount? And if we are paying Advent to manufacture something, why is there no "manufacturing" line on the income statement that shows total operating costs and expenses?

(Sorry I missed the June 29 shareholders meeting. Perhaps the answer to this riddle was given then.)

Thanks!

-- OJ